Savard, Josée https://orcid.org/0000-0002-8052-1046
Filion, Catherine
Gagnon, Marie-Pierre
Caplette-Gingras, Aude
Bélanger, Lynda
Morin, Charles M.
Funding for this research was provided by:
Canadian Institutes of Health Research (156376)
Canadian Cancer Society (705654-1)
Article History
Received: 26 October 2021
Accepted: 25 April 2022
First Online: 4 May 2022
Declarations
:
: This study was approved by the ethics’ committee of each participating institution (CHU de Québec-Université Laval: #MP-20–2020-4796; CISSS de Chaudière-Appalaches (Hôtel-Dieu de Lévis): #MEO-20–2020-711; Institut universitaire en cardiologie et pneumologique de Québec: #MEO-20–2021-3408).
: All participants signed a consent form.
: Not applicable.
: Josée Savard reports the following conflict of interest: Astellas (consultant). Charles Morin reports the following conflicts of interests: Advisory boards: Eisai, Merck, Sunovion, Pear Therapeutics, Weight Watchers; Research Grant: Idorsia, Canopy Health. The other authors report no conflicts of interest.